U.S. Markets open in 2 hrs 51 mins

ResMed Inc. (RSMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
25.060.00 (0.00%)
At close: 12:44PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close25.06
BidN/A x N/A
AskN/A x N/A
Day's Range25.06 - 25.06
52 Week Range17.50 - 29.74
Avg. Volume1,295
Market Cap38.845B
Beta (5Y Monthly)0.30
PE Ratio (TTM)32.04
Earnings DateN/A
Forward Dividend & Yield0.16 (0.59%)
Ex-Dividend DateMay 12, 2021
1y Target EstN/A
  • Motley Fool

    3 Leading Healthcare Stocks to Buy in 2021 and Beyond

    Resmed (NYSE: RMD), Walgreens Boots Alliance (NASDAQ: WBA) and AbbVie (NYSE: ABBV) are profitable companies that have clear paths to future revenue growth. ResMed is already an industry leader in sleep apnea therapies, an area that's expected to grow as our population ages. Walgreens Boots Alliance is jumping onto the trend toward value-oriented healthcare services, and AbbVie's huge stable of drugs and pipeline give it a diversity that protects its long-term outlook.

  • Benzinga

    Notable Resmed Insider Trades $1.4M In Company Stock

    Brett Sandercock, Chief Financial Officer at Resmed (NYSE:RMD), made a large buy and sell of company shares on October 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Brett Sandercock exercised options to purchase 2,500 Resmed shares at a price of $57.76 per share for a total of $144,400 on October 11. They then sold their shares on the same day in the open market. They sold at a price of $253.37 to raise a total of $

  • Motley Fool

    3 Top Healthcare Stocks to Buy Right Now

    After all, Wall Street doesn't sell a stock unless it believes there is a better place for the money -- at least in the short term. Knowing you plan to hold for years, and not having anyone but yourself to answer to, can focus your analysis on the company and its prospects. As company reputations go, Johnson & Johnson offers one of the strangest juxtapositions.